Cargando…

Influence of vaccination and prior immunity on the dynamics of Omicron BA.1 and BA.2 sub-variants

Detalles Bibliográficos
Autores principales:	Dimeglio, Chloé, Loubes, Jean-Michel, Migueres, Marion, Sauné, Karine, Trémeaux, Pauline, Lhomme, Sébastien, Ranger, Noémie, Latour, Justine, Mansuy, Jean-Michel, Izopet, Jacques
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The British Infection Association. Published by Elsevier Ltd. 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926943/ https://www.ncbi.nlm.nih.gov/pubmed/35307410 http://dx.doi.org/10.1016/j.jinf.2022.03.014

Ejemplares similares

Influence of immune escape and nasopharyngeal virus load on the spread of SARS-CoV-2 Omicron variant
por: Migueres, Marion, et al.
Publicado: (2022)

Influence of SARS-CoV-2 Variant B.1.1.7, Vaccination, and Public Health Measures on the Spread of SARS-CoV-2
por: Dimeglio, Chloé, et al.
Publicado: (2021)

Antibody Titers and Protection against Omicron (BA.1 and BA.2) SARS-CoV-2 Infection
por: Dimeglio, Chloé, et al.
Publicado: (2022)

Prediction of SARS-CoV-2 Variant Lineages Using the S1-Encoding Region Sequence Obtained by PacBio Single-Molecule Real-Time Sequencing
por: Lhomme, Sébastien, et al.
Publicado: (2021)

Will the latest wave of the COVID‐19 pandemic be an ecological disaster? There is an urgent need to replace plastic by ecologically virtuous materials
por: Mansuy, Jean‐Michel, et al.
Publicado: (2022)

Antibody titers and breakthrough infections with Omicron SARS-CoV-2
por: Dimeglio, Chloé, et al.
Publicado: (2022)

Omicron Wave SARS-CoV-2 Diagnosis: Evaluation of Saliva, Anterior Nasal, and Nasopharyngeal Swab Samples
por: Migueres, Marion, et al.
Publicado: (2022)

The SARS-CoV-2 seroprevalence is the key factor for deconfinement in France
por: Dimeglio, Chloé, et al.
Publicado: (2020)

Evaluation of two RT-PCR screening assays for identifying SARS-CoV-2 variants
por: Migueres, M., et al.
Publicado: (2021)

Quantifying the impact of public health protection measures on the spread of SARS-CoV-2
por: Dimeglio, Chloé, et al.
Publicado: (2021)

Influence of the Delta Variant and Vaccination on the SARS-CoV-2 Viral Load
por: Migueres, Marion, et al.
Publicado: (2022)

Side effect of a 6 p.m curfew for preventing the spread of SARS-CoV-2: A modeling study from Toulouse, France
por: Dimeglio, Chloé, et al.
Publicado: (2021)

Estimating the impact of public health strategies on the spread of SARS‐CoV‐2: Epidemiological modelling for Toulouse, France
por: Dimeglio, Chloé, et al.
Publicado: (2021)

Whole‐genome sequencing of SARS‐CoV‐2: Comparison of target capture and amplicon single molecule real‐time sequencing protocols
por: Nicot, Florence, et al.
Publicado: (2022)

Resistance mutations in SARS-CoV-2 omicron variant in patients treated with sotrovimab
por: Vellas, Camille, et al.
Publicado: (2022)

Saliva sampling for diagnosing SARS-CoV-2 infections in symptomatic patients and asymptomatic carriers
por: Migueres, Marion, et al.
Publicado: (2020)

Omicron BA.5 Neutralization among Vaccine-Boosted Persons with Prior Omicron BA.1/BA.2 Infections
por: Pedersen, Rune M., et al.
Publicado: (2022)

Evaluation of the Aptima™ transcription-mediated amplification assay (Hologic®) for detecting SARS-CoV-2 in clinical specimens
por: Trémeaux, Pauline, et al.
Publicado: (2020)

Classification of the Zoonotic Hepatitis E Virus Genotype 3 Into Distinct Subgenotypes
por: Nicot, Florence, et al.
Publicado: (2021)

Vaccine- and Breakthrough Infection-Elicited Pre-Omicron Immunity More Effectively Neutralizes Omicron BA.1, BA.2, BA.4 and BA.5 Than Pre-Omicron Infection Alone
por: Santos da Silva, Eveline, et al.
Publicado: (2023)

Testing individual and pooled saliva samples for sars-cov-2 nucleic acid: a prospective study
por: Migueres, Marion, et al.
Publicado: (2021)

BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants
por: Rössler, Annika, et al.
Publicado: (2022)

The real seroprevalence of SARS-CoV-2 in France and its consequences for virus dynamics
por: Dimeglio, Chloé, et al.
Publicado: (2021)

Hepatitis E Virus Infection without Reactivation in Solid-Organ Transplant Recipients, France
por: Legrand-Abravanel, Florence, et al.
Publicado: (2011)

Antibody evasion of SARS-CoV-2 Omicron BA.1, BA.1.1, BA.2, and BA.3 sub-lineages
por: Ai, Jingwen, et al.
Publicado: (2022)

A booster of Delta-Omicron RBD-dimer protein subunit vaccine augments sera neutralization of Omicron sub-variants BA.1/BA.2/BA.2.12.1/BA.4/BA.5
por: Duan, Minrun, et al.
Publicado: (2023)

Omicron Sub-Lineages (BA.1.1.529 + BA.*) Current Status in Ecuador
por: Carrazco-Montalvo, Andrés, et al.
Publicado: (2022)

Neutralization of SARS-CoV-2 Omicron sub-lineages BA.1, BA.1.1, and BA.2
por: Evans, John P., et al.
Publicado: (2022)

Children are protected against SARS-CoV-2 infection
por: Dimeglio, Chloé, et al.
Publicado: (2020)

Post-vaccination SARS-CoV-2 antibody kinetics and protection duration against Omicron in elderly population
por: Dimeglio, Chloé, et al.
Publicado: (2022)

SARS-CoV-2 Co-Infections and Recombinations Identified by Long-Read Single-Molecule Real-Time Sequencing
por: Trémeaux, Pauline, et al.
Publicado: (2023)

Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection
por: Khan, Khadija, et al.
Publicado: (2022)

Hepatitis A: Epidemiology, High-Risk Groups, Prevention and Research on Antiviral Treatment
por: Migueres, Marion, et al.
Publicado: (2021)

Neutralization of Omicron BA.4/BA.5 and BA.2.75 by booster vaccination or BA.2 breakthrough infection sera
por: Wang, Xun, et al.
Publicado: (2022)

Omicron BA.2 breakthrough infection enhances cross-neutralization of BA.2.12.1 and BA.4/BA.5
por: Muik, Alexander, et al.
Publicado: (2022)

Antibody Response to Omicron BA.4–BA.5 Bivalent Booster
por: Wang, Qian, et al.
Publicado: (2023)

Effects of BA.1/BA.2 subvariant, vaccination and prior infection on infectiousness of SARS-CoV-2 omicron infections
por: Qassim, Suelen H, et al.
Publicado: (2022)

1966. Protection afforded by prior infection, vaccination, and hybrid immunity against symptomatic BA.1 and BA.2 Omicron infections.
por: Altarawneh, Heba N, et al.
Publicado: (2022)

BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection
por: Cao, Yunlong, et al.
Publicado: (2022)

Outcomes of Omicron sub-lineages BA.1.1 and BA.2 infection compared with the sub-lineage BA.1 infection in emergency departments' patients
por: Bouzid, Donia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_iaa1bc13qfk867d1phjcpk2sdq